Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort

It is of much interest to understand the efficacy of abiraterone acetate (AA) in routine clinical practice. We assessed the clinical outcome of AA in patients with metastatic castration-resistant prostate cancer (mCRPC) and determined clinical factors associated with AA treatment duration in real-wo...

Full description

Saved in:
Bibliographic Details
Main Authors: Lim, Jasmine, Amantakul, Akara, Shariff, Nisha, Lojanapiwat, Bannakij, Alip, Adlinda, Ong, Teng Aik, Thevarajah, Shankaran, Ahmayuddin, Firdaus, Mathew, Adeline, Sriplakich, Supon, Vuthiwong, Jaraspong, Chong, Flora Li Tze, Saad, Marniza
Format: Article
Published: Wiley Open Access 2020
Subjects:
RD Surgery
Online Access:http://eprints.um.edu.my/36695/
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Malaya

Internet

http://eprints.um.edu.my/36695/

Similar Items